Literature DB >> 26315439

HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.

John T Hinson1, Anant Chopra2, Navid Nafissi3, William J Polacheck2, Craig C Benson4, Sandra Swist5, Joshua Gorham3, Luhan Yang6, Sebastian Schafer7, Calvin C Sheng3, Alireza Haghighi8, Jason Homsy3, Norbert Hubner9, George Church6, Stuart A Cook10, Wolfgang A Linke5, Christopher S Chen2, J G Seidman3, Christine E Seidman11.   

Abstract

Human mutations that truncate the massive sarcomere protein titin [TTN-truncating variants (TTNtvs)] are the most common genetic cause for dilated cardiomyopathy (DCM), a major cause of heart failure and premature death. Here we show that cardiac microtissues engineered from human induced pluripotent stem (iPS) cells are a powerful system for evaluating the pathogenicity of titin gene variants. We found that certain missense mutations, like TTNtvs, diminish contractile performance and are pathogenic. By combining functional analyses with RNA sequencing, we explain why truncations in the A-band domain of TTN cause DCM, whereas truncations in the I band are better tolerated. Finally, we demonstrate that mutant titin protein in iPS cell-derived cardiomyocytes results in sarcomere insufficiency, impaired responses to mechanical and β-adrenergic stress, and attenuated growth factor and cell signaling activation. Our findings indicate that titin mutations cause DCM by disrupting critical linkages between sarcomerogenesis and adaptive remodeling.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26315439      PMCID: PMC4618316          DOI: 10.1126/science.aaa5458

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

1.  A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues.

Authors:  Thomas Boudou; Wesley R Legant; Anbin Mu; Michael A Borochin; Nimalan Thavandiran; Milica Radisic; Peter W Zandstra; Jonathan A Epstein; Kenneth B Margulies; Christopher S Chen
Journal:  Tissue Eng Part A       Date:  2012-01-04       Impact factor: 3.845

2.  microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling.

Authors:  Benzhi Cai; Jianping Li; Jinghao Wang; Xiaobin Luo; Jing Ai; Yanju Liu; Ning Wang; Haihai Liang; Mingyu Zhang; Nan Chen; Gang Wang; Shu Xing; Xin Zhou; Baofeng Yang; Xinyue Wang; Yanjie Lu
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

3.  Reprogramming of T cells from human peripheral blood.

Authors:  Yuin-Han Loh; Odelya Hartung; Hu Li; Chunguang Guo; Julie M Sahalie; Philip D Manos; Achia Urbach; Garrett C Heffner; Marica Grskovic; Francois Vigneault; M William Lensch; In-Hyun Park; Suneet Agarwal; George M Church; James J Collins; Stefan Irion; George Q Daley
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

4.  Construction of normalized RNA-seq libraries for next-generation sequencing using the crab duplex-specific nuclease.

Authors:  Danos C Christodoulou; Joshua M Gorham; Daniel S Herman; J G Seidman
Journal:  Curr Protoc Mol Biol       Date:  2011-04

Review 5.  Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction.

Authors:  Wolfgang A Linke
Journal:  Cardiovasc Res       Date:  2008-03-01       Impact factor: 10.787

6.  Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction.

Authors:  Lorena Zentilin; Uday Puligadda; Vincenzo Lionetti; Serena Zacchigna; Chiara Collesi; Lucia Pattarini; Giulia Ruozi; Silvia Camporesi; Gianfranco Sinagra; Martino Pepe; Fabio A Recchia; Mauro Giacca
Journal:  FASEB J       Date:  2009-12-17       Impact factor: 5.191

7.  MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes.

Authors:  Sadakatsu Ikeda; Aibin He; Sek Won Kong; Jun Lu; Rafael Bejar; Natalya Bodyak; Kyu-Ho Lee; Qing Ma; Peter M Kang; Todd R Golub; William T Pu
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

Review 8.  MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.

Authors:  Eva van Rooij; Eric N Olson
Journal:  Nat Rev Drug Discov       Date:  2012-10-19       Impact factor: 84.694

9.  Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.

Authors:  Angharad M Roberts; James S Ware; Daniel S Herman; Sebastian Schafer; John Baksi; Alexander G Bick; Rachel J Buchan; Roddy Walsh; Shibu John; Samuel Wilkinson; Francesco Mazzarotto; Leanne E Felkin; Sungsam Gong; Jacqueline A L MacArthur; Fiona Cunningham; Jason Flannick; Stacey B Gabriel; David M Altshuler; Peter S Macdonald; Matthias Heinig; Anne M Keogh; Christopher S Hayward; Nicholas R Banner; Dudley J Pennell; Declan P O'Regan; Tan Ru San; Antonio de Marvao; Timothy J W Dawes; Ankur Gulati; Emma J Birks; Magdi H Yacoub; Michael Radke; Michael Gotthardt; James G Wilson; Christopher J O'Donnell; Sanjay K Prasad; Paul J R Barton; Diane Fatkin; Norbert Hubner; Jonathan G Seidman; Christine E Seidman; Stuart A Cook
Journal:  Sci Transl Med       Date:  2015-01-14       Impact factor: 17.956

10.  Truncations of titin causing dilated cardiomyopathy.

Authors:  Daniel S Herman; Lien Lam; Matthew R G Taylor; Libin Wang; Polakit Teekakirikul; Danos Christodoulou; Lauren Conner; Steven R DePalma; Barbara McDonough; Elizabeth Sparks; Debbie Lin Teodorescu; Allison L Cirino; Nicholas R Banner; Dudley J Pennell; Sharon Graw; Marco Merlo; Andrea Di Lenarda; Gianfranco Sinagra; J Martijn Bos; Michael J Ackerman; Richard N Mitchell; Charles E Murry; Neal K Lakdawala; Carolyn Y Ho; Paul J R Barton; Stuart A Cook; Luisa Mestroni; J G Seidman; Christine E Seidman
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

View more
  219 in total

Review 1.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

Review 2.  Tissue-Engineering for the Study of Cardiac Biomechanics.

Authors:  Stephen P Ma; Gordana Vunjak-Novakovic
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

3.  Genetics of CVD in 2015: Using genomic approaches to identify CVD-causing variants.

Authors:  Donna K Arnett
Journal:  Nat Rev Cardiol       Date:  2016-01-14       Impact factor: 32.419

Review 4.  Modelling sarcomeric cardiomyopathies with human cardiomyocytes derived from induced pluripotent stem cells.

Authors:  Lorenzo R Sewanan; Stuart G Campbell
Journal:  J Physiol       Date:  2019-02-06       Impact factor: 5.182

Review 5.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

6.  Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy.

Authors:  Sarah R Clippinger; Paige E Cloonan; Lina Greenberg; Melanie Ernst; W Tom Stump; Michael J Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

7.  Transient Support from Fibroblasts is Sufficient to Drive Functional Vascularization in Engineered Tissues.

Authors:  H-H Greco Song; Alex Lammers; Subramanian Sundaram; Logan Rubio; Amanda X Chen; Linqing Li; Jeroen Eyckmans; Sangeeta N Bhatia; Christopher S Chen
Journal:  Adv Funct Mater       Date:  2020-06-25       Impact factor: 18.808

Review 8.  Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models.

Authors:  Katya D'Costa; Milena Kosic; Angus Lam; Azeen Moradipour; Yimu Zhao; Milica Radisic
Journal:  Ann Biomed Eng       Date:  2020-04-13       Impact factor: 3.934

9.  Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy.

Authors:  Jiayang Li; Kenneth S Gresham; Ranganath Mamidi; Chang Yoon Doh; Xiaoping Wan; Isabelle Deschenes; Julian E Stelzer
Journal:  Int J Cardiol       Date:  2018-09-21       Impact factor: 4.164

Review 10.  Engineering cardiac microphysiological systems to model pathological extracellular matrix remodeling.

Authors:  Nethika R Ariyasinghe; Davi M Lyra-Leite; Megan L McCain
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.